Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in SGMO held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | ARMISTICE CAPITAL, LLC | 40.4M | $10.0M | β | 9.752% | 0.29% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 12.7M | $3.1M | β | 3.067% | 0.00% |
| 3 | TWO SIGMA INVESTMENTS, LP | 6.3M | $1.5M | +31.8% | 1.513% | 0.00% |
| 4 | BALYASNY ASSET MANAGEMENT LLC | 5.3M | $1.3M | β | 1.276% | 0.00% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 4.6M | $1.1M | +18.2% | 1.103% | 0.00% |
| 6 | BlackRock, Inc. | 4.5M | $1.1M | -0.5% | 1.098% | 0.00% |
| 7 | RENAISSANCE TECHNOLOGIES LLC | 3.8M | $947K | -54.5% | 0.926% | 0.00% |
| 8 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2.8M | $683K | -12.8% | 0.664% | 0.00% |
| 9 | UBS Group AG | 2.6M | $635K | +151.0% | 0.621% | 0.00% |
| 10 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.4M | $581K | +37.3% | 0.568% | 0.00% |
| 11 | VANGUARD FIDUCIARY TRUST CO | 2.3M | $571K | β | 0.558% | 0.00% |
| 12 | JACOBS LEVY EQUITY MANAGEMENT, INC | 2.1M | $506K | +95.1% | 0.495% | 0.00% |
| 13 | BANK OF AMERICA CORP /DE/ | 1.8M | $452K | +1856.1% | 0.444% | 0.00% |
| 14 | STATE STREET CORP | 1.7M | $418K | +25.0% | 0.409% | 0.00% |
| 15 | LUMINUS MANAGEMENT LLC | 1.7M | $415K | +45.1% | 0.406% | 0.25% |
| 16 | Ikarian Capital, LLC | 1.2M | $301K | 0.0% | 0.294% | 0.03% |
| 17 | Invesco Ltd. | 1.0M | $258K | +4.5% | 0.252% | 0.00% |
| 18 | NORTHERN TRUST CORP | 738K | $182K | 0.0% | 0.178% | 0.00% |
| 19 | HighTower Advisors, LLC | 706K | $174K | +0.3% | 0.170% | 0.00% |
| 20 | SANDERS MORRIS HARRIS LLC | 668K | $165K | β | 0.161% | 0.03% |
| 21 | MAK CAPITAL ONE LLC | 562K | $139K | β | 0.136% | 0.02% |
| 22 | MORGAN STANLEY | 423K | $105K | -0.1% | 0.102% | 0.00% |
| 23 | NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 400K | $99K | 0.0% | 0.097% | 0.00% |
| 24 | CANADA PENSION PLAN INVESTMENT BOARD | 397K | $98K | +57.6% | 0.096% | 0.00% |
| 25 | GOLDMAN SACHS GROUP INC | 377K | $93K | +97.9% | 0.091% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in SGMO β a direct measure of their conviction.
Filings activity in SGMO during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 110 | +5.8% | 40.43% | 0.43 pp | $26M | 1.1% |
| Q4 2025 | 104 | 5.5% | 40.86% | 38.70 pp | $27M | 49% |
| Q3 2025 | 110 | 2.7% | 79.56% | +37.92 pp | $52M | +91% |
| Q2 2025 | 113 | 7.4% | 41.64% | 11.68 pp | $27M | 22% |
| Q1 2025 | 122 | 3.9% | 53.32% | 40.79 pp | $35M | 43% |
| Q4 2024 | 127 | +22% | 94.11% | +19.72 pp | $61M | +27% |
| Q3 2024 | 104 | 19% | 74.39% | +10.00 pp | $48M | +16% |
| Q2 2024 | 128 | β | 64.39% | β | $42M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying SGMO stock.
Based on Q1 2026 13F filings, institutional ownership of Sangamo Therapeutics, Inc. stands at 40.4%, held across 110 reporting institutions.
ARMISTICE CAPITAL, LLC is the largest reported institutional holder of SGMO, with approximately 40,400,067 shares worth $0.01B as of Q1 2026.
Yes β 3 widely-followed marquee investors appear among the top 25 institutional holders of SGMO, including TWO SIGMA INVESTMENTS, LP, RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP.
Our composite Smart Money Score for SGMO is 58 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
28 institutions opened new positions in SGMO during Q1 2026, while 22 fully exited. 10 added to existing positions and 70 trimmed.
SGMO institutional ownership fell by 0.43 percentage points quarter-over-quarter, with a net change of +6 holders.
The top 10 institutions account for 80.2% of all reported 13F value in SGMO, and the top 25 account for 95.3%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Sangamo Therapeutics, Inc. (SGMO) Institutional Ownership